These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 34895325)
1. Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infection. Keshtkarjahromi M; Chhetri S; Balagani A; Tayyab UB; Haas CJ BMC Rheumatol; 2021 Dec; 5(1):59. PubMed ID: 34895325 [TBL] [Abstract][Full Text] [Related]
2. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review. Stewart JA; Price T; Moser S; Mullikin D; Bryan A Pediatr Rheumatol Online J; 2022 Feb; 20(1):16. PubMed ID: 35193600 [TBL] [Abstract][Full Text] [Related]
3. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report. Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894 [TBL] [Abstract][Full Text] [Related]
4. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review]. Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559 [No Abstract] [Full Text] [Related]
5. Macrophage activation syndrome as a complication of dermatomyositis: A case report. Zhu DX; Qiao JJ; Fang H World J Clin Cases; 2020 Jun; 8(11):2339-2344. PubMed ID: 32548165 [TBL] [Abstract][Full Text] [Related]
7. Case Report: Treatment of Anti-MDA5-Positive Amyopathic Dermatomyositis Accompanied by a Rapidly Progressive Interstitial Lung Diseases With Methylprednisolone Pulse Therapy Combined With Cyclosporine A and Hydroxychloroquine. Zhang QC; Liu MY; Chen ZX; Chen YT; Lin CS; Xu Q Front Med (Lausanne); 2020; 7():610554. PubMed ID: 33330573 [No Abstract] [Full Text] [Related]
9. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report. De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518 [TBL] [Abstract][Full Text] [Related]
10. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum. Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335 [TBL] [Abstract][Full Text] [Related]
11. Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis. Fujita Y; Fukui S; Suzuki T; Ishida M; Endo Y; Tsuji S; Takatani A; Igawa T; Shimizu T; Umeda M; Sumiyoshi R; Nishino A; Koga T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Abe K; Kawakami A Intern Med; 2018 Dec; 57(23):3473-3478. PubMed ID: 29984753 [TBL] [Abstract][Full Text] [Related]
12. Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy. Ge Y; Li S; Tian X; He L; Lu X; Wang G Clin Rheumatol; 2021 Jun; 40(6):2311-2317. PubMed ID: 33411136 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous Pneumomediastinum due to Anti-Melanoma Differentiation-Associated Protein 5 Requiring a Bilateral Lung Transplant. Jhajj AS; Shun Yeung JH; To F Case Rep Rheumatol; 2021; 2021():6097183. PubMed ID: 34745682 [TBL] [Abstract][Full Text] [Related]
14. A case of anti-MDA5 antibody-positive dermatomyositis developing reversible cerebral vasospasm syndrome successfully treated by multi-immunosuppressant combination including mycophenolate mofetil. Muramatsu T; Tono T; Kanayama Y; Hasegawa Y; Kondo J; Hoshiyama T; Wada T; Arinuma Y; Tanaka S; Yamaoka K Mod Rheumatol Case Rep; 2021 Jan; 5(1):69-75. PubMed ID: 32811369 [TBL] [Abstract][Full Text] [Related]
15. Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody. Parperis K; Kiyani A BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301801 [TBL] [Abstract][Full Text] [Related]
16. [Severe MDA5 dermatomyositis associated with cancer and controlled by JAK inhibitor]. Jalles C; Deroux A; Tardieu M; Lugosi M; Viel S; Benveniste O; Colombe B Rev Med Interne; 2020 Jun; 41(6):421-424. PubMed ID: 32192753 [TBL] [Abstract][Full Text] [Related]
17. Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom. Hattori Y; Matsuyama K; Takahashi T; Shu E; Kanoh H; Seishima M Case Rep Dermatol; 2018; 10(2):110-114. PubMed ID: 29867431 [TBL] [Abstract][Full Text] [Related]
18. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease. Motegi SI; Sekiguchi A; Toki S; Kishi C; Endo Y; Yasuda M; Ikeuchi H; Sakairi T; Hara K; Yamaguchi K; Maeno T; Hiromura K; Ishikawa O Eur J Dermatol; 2019 Oct; 29(5):511-517. PubMed ID: 31617496 [TBL] [Abstract][Full Text] [Related]
19. Macrophage activation syndrome in juvenile dermatomyositis: a systematic review. Poddighe D; Dauyey K Rheumatol Int; 2020 May; 40(5):695-702. PubMed ID: 31529231 [TBL] [Abstract][Full Text] [Related]